Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway

Fig. 1

Effect of linagliptin treatment on motor function and infarct volume. a Forepaw grip strength at Day 3 and b 3 weeks after MCAO. c Infarct volume 3 weeks after MCAO. d Photomicrographs of NeuN immunoreactivity. Dashed line outlines the area of visible ischemic damage after MCAO. Unpaired t test with Welch’s correction, mean ± SD. * and ** denote p < 0.05 and p < 0.01 respectively

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840